71 Results

People

  1. Landgren
    Landgren
  2. Sadelain
    Sadelain
  3. Brentjens
    Brentjens
  4. Korde
    Korde
  5. Mailankody
    Mailankody
  6. Hsu
    Hsu
  7. Lesokhin
    Lesokhin
  8. Park
    Park
  9. Scheinberg
    Scheinberg
  10. Purdon
    Purdon

Groups

  1. Center for Hematologic Malignancies (71)
  2. Hematologic Malignancies Research (71)
  3. Department of Medicine (61)
  4. Hematologic Malignancies, Division of (54)
  5. GSK Faculty (51)
  6. Sloan Kettering Institute Faculty (36)
  7. Molecular Pharmacology and Chemistry Program Faculty (31)
  8. Sloan Kettering Institute Postdocs (28)
  9. Tow Center for Developmental Oncology (TCDO) (26)
  10. Myeloma (22)
  1. "Hematologic Malignancies Research"
  2. "2016"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (71)
Groups
  1. Center for Hematologic Malignancies (71)
  2. Hematologic Malignancies Research (71)
  3. Department of Medicine (61)
  4. Hematologic Malignancies, Division of (54)
  5. GSK Faculty (51)
  6. Sloan Kettering Institute Faculty (36)

More Groups

People
  1. Carl Landgren (18)
  2. Michel Sadelain (14)
  3. Neha Korde (11)
  4. Renier Brentjens (11)
  5. Sham Mailankody (10)
  6. Alexander Lesokhin (8)

More People

Years
  1. 2016 (71)
Publications
  1. Blood (38)
  2. Haematologica (7)
  3. Journal of Clinical Oncology (5)
  4. Journal of Immunology (4)
  5. Molecular Therapy (3)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. American Society of Hematology (38)
  2. Ferrata Storti Foundation (7)
  3. American Society of Clinical Oncology (5)
  4. Elsevier Inc. (5)
  5. Nature Publishing Group (4)
  6. The American Association of Immunologists, Inc (4)

More Publishers

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High PRMT1 expression promotes the progression of acute megakaryocytic leukemia via controlling metabolic pathways
    Meeting Abstract

    Su, H.; Guo, H.; Tran, N. T.; Luo, M.; Zhao, X.
    Blood (2016)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling for improved diagnosis and therapy of pediatric acute leukemias
    Meeting Abstract

    Kobos, R.; He, J.; Steinherz, P. G.; Curran, K. J.; Renaud, T. M.; Forlenza, C.; Boulad, F.; Prockop, S.; Knapp, K. M.; Walsh, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Impact of disease burden on long-term outcome of 19-28z CAR modified T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genetic plasma cell signatures in high-risk smoldering myeloma versus multiple myeloma patients
    Meeting Abstract

    Mailankody, S.; Korde, N.; Roschewski, M. J.; Christofferson, A.; Boateng, M.; Zhang, Y.; Manasanch, E. E.; Kazandjian, D. G.; Kwok, M.; Bhutani, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Updated results: Phase I trial of autologous CD19-targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A turbocharged chimeric antigen receptor against prostate cancer
    Meeting Abstract

    Zhao, Z.; Hamieh, M.; Eyquem, J.; Gunset, G.; Bander, N.; Sadelain, M.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • RNA binding protein SYNCRIP regulates the leukemia stem cell program
    Meeting Abstract

    Vu, L. P.; Prieto, C.; Amin, E.; Minuesa, G.; Chhangawala, S.; Vidal, M. J.; Krivtsov, A. V.; Chou, T.; Barlowe, T.; Taggart, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Murine donor 1928z CAR T cells exert potent graft-versus-lymphoma activity without graft-versus-host-disease
    Meeting Abstract

    Smith, M.; Ghosh, A.; James, S.; Davila, M. L.; Velardi, E.; Argyropoulos, K. V.; Gunset, G.; Schietinger, A.; Sadelain, M. W.; van den Brink, M.
    Blood (2016)

    Fulltext@MSK | Save